Stay updated on ABSK-021 Safety in Solid Tumor Patients Clinical Trial
Sign up to get notified when there's something new on the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page.

Latest updates to the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded site revision tag 'Revision: v3.4.2'. Deleted items include a funding-status notice and the earlier 'Revision: v3.4.1' notice.SummaryDifference0.4%

- Check26 days agoChange DetectedAdded a government funding notice at the top of the page and updated site revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check33 days agoChange DetectedThe page adds a glossary toggle and updated metadata labels, including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with revised capitalization, and updates the revision to v3.4.0, replacing the previous v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check47 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page. This appears to be a minor version update and does not affect study content.SummaryDifference0.0%

- Check69 days agoChange DetectedExpanded list of trial locations across the United States and China (e.g., California, Colorado, Georgia, Texas, Beijing, Guangzhou, Hebei, Henan, Jiangsu, Liaoning, Shanghai, Shanxi, Sichuan, Zhejiang). Some previously listed location blocks were removed.SummaryDifference1%

- Check90 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed, updating the page's revision tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to ABSK-021 Safety in Solid Tumor Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page.